Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice

Infection and Immunity

Volumn 77, Issue 6, 2009, Pages 2508-2516

  Shen, Z ^a   Feng, Y ^a   Rogers, A B ^a   Rickman, B ^a   Whary, M T ^a   Xu, S ^a   Clapp, K M ^a   Boutin, S R ^a   Fox, J G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CECUM; COLITIS; COLON; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DYSPLASIA; FEMALE; GENE EXPRESSION REGULATION; HELICOBACTER CINAEDI; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNOMODULATION; INFLAMMATION; LIVER; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE SECTION; TYPHLITIS; WILD TYPE; ANIMAL; C57BL MOUSE; GENETICS; HELICOBACTER; HELICOBACTER INFECTION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

ANIMALS; BACTERIAL TOXINS; COLITIS; FEMALE; HELICOBACTER; HELICOBACTER INFECTIONS; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; TYPHLITIS;

EID: 66549121984     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00166-09     Document Type: Article

References (57)

1. Boivin, G. P., K. Washington, and K. Yang. 2003. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastoenterology 124:762-777. (Pubitemid 36268493)
2. Burman, W. J., D. L. Cohn, R. R. Reves, and M. L. Wilson. 1995. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin. Infect. Dis. 20:564-570.
3. Cahill, R. J., C. J. Foltz, J. G. Fox, C. A. Dangler, F. Powrie, and D. B. Schauer. 1997. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65:3126-3131. (Pubitemid 27342388)
4. Chien, C. C., N. S. Taylor, Z. Ge, D. B. Schauer, V. B. Young, and J. G. Fox. 2000. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J. Med. Microbiol. 49:525-534. (Pubitemid 30347590)
5. 2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect. Immun. 65:5088-5095.
6. Comunian, L. B., S. B. Moura, A. P. Paglia, J. R. Nicoli, J. B. Guerra, G. A. Rocha, and D. M. Queiroz. 2006. Detection of Helicobacter species in the gastrointestinal tract of wild rodents from Brazil. Curr. Microbiol. 53:370-373.
7. Cortes-Bratti, X., E. Chaves-Olarte, T. Lagergard, and M. Thelestam. 1999. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J. Clin. Investig. 103:107-115.
8. Eaton, K. A. 2006. Response to "eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice." Helicobacter 11:135-136. (Pubitemid 43363314)
9. Erdman, S. E., V. P. Rao, T. Poutahidis, M. M. Ihrig, Z. Ge, Y. Feng, M. Tomczak, A. B. Rogers, B. H. Horwitz, and J. G. Fox. 2003. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63:6042-6050. (Pubitemid 37187508)
10. Erdman, S. E., V. P. Rao, T. Poutahidis, A. B. Rogers, C. L. Taylor, E. A. Jackson, Z. Ge, C. W. Lee, D. B. Schauer, G. N. Wogan, S. R. Tannenbaum, and J. G. Fox. 2009. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc. Natl. Acad. Sci. USA 106:1027-1032.
11. Fernandez, K. R., L. M. Hansen, P. Vandamme, B. L. Beaman, and J. V. Solnick. 2002. Captive rhesus monkeys (Macaca mulatta) are commonly infected with Helicobacter cinaedi. J. Clin. Microbiol. 40:1908-1912.
12. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205. (Pubitemid 28307304)
13. Fox, J. G. 2002. The non-H. pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 50:273-283.
14. Fox, J. G., P. L. Gorelick, M. C. Kullberg, Z. Ge, F. E. Dewhirst, and J. M. Ward. 1999. A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice. Infect. Immun. 67:1757-1762.
15. Fox, J. G., L. Handt, B. J. Sheppard, S. Xu, F. E. Dewhirst, S. Motzel, and H. Klein. 2001. Isolation of Helicobacter cinaedi from the colon, liver, and mesenteric lymph node of a rhesus monkey with chronic colitis and hepatitis. J. Clin. Microbiol. 39:1580-1585.
16. Fox, J. G., A. B. Rogers, M. T. Whary, Z. Ge, N. S. Taylor, S. Xu, B. H. Horwitz, and S. E. Erdman. 2004. Gastroenteritis in NF-κB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect. Immun. 72:1116-1125.
17. Fox, J. G., L. Yan, B. Shames, J. Campbell, J. C. Murphy, and X. Li. 1996. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect. Immun. 64:3673-3681.
18. Garcia, A., S. Xu, F. E. Dewhirst, P. R. Nambiar, and J. G. Fox. 2006. Enterohepatic Helicobacter species isolated from the ileum, liver and colon of a baboon with pancreatic islet amyloidosis. J. Med. Microbiol. 55:1591-1595.
19. Ge, Z., Y. Feng, M. T. Whary, P. R. Nambiar, S. Xu, V. Ng, N. S. Taylor, and J. G. Fox. 2005. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect. Immun. 73:3559-3567.
20. Ge, Z., A. B. Rogers, Y. Feng, A. Lee, S. Xu, N. S. Taylor, and J. G. Fox. 2007. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell. Microbiol. 9:2070-2080.
21. Ge, Z., and D. E. Taylor. 1997. The Helicobacter pylori gene encoding phosphatidylserine synthase: sequence, expression, and insertional mutagenesis. J. Bacteriol. 179:4970-4976.
22. Ge, Z., D. A. White, M. T. Whary, and J. G. Fox. 2001. Fluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticus. J. Clin. Microbiol. 39:2598-2602.
23. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J. E. de Vries, and M. G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742. (Pubitemid 27458961)
24. Hickey, T. E., A. L. McVeigh, D. A. Scott, R. E. Michielutti, A. Bixby, S. A. Carroll, A. L. Bourgeois, and P. Guerry. 2000. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect. Immun. 68:6535-6541.
25. Ihrig, M., M. D. Schrenzel, and J. G. Fox. 1999. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am. J. Pathol. 155:571-582.
26. Jankovic, D., M. C. Kullberg, S. Hieny, P. Caspar, C. M. Collazo, and A. Sher. 2002. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity 16:429-439.
27. Kimura, H., R. Hokari, S. Miura, T. Shigematsu, M. Hirokawa, Y. Akiba, I. Kurose, H. Higuchi, H. Fujimori, Y. Tsuzuki, H. Serizawa, and H. Ishii. 1998. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 42:180-187. (Pubitemid 28212172)
28. Kitamura, T., Y. Kawamura, K. Ohkusu, T. Masaki, H. Iwashita, T. Sawa, S. Fujii, T. Okamoto, and T. Akaike. 2007. Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery. J. Clin. Microbiol. 45:31-38.
29. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274. (Pubitemid 23320290)
30. Kullberg, M. C., J. F. Andersen, P. L. Gorelick, P. Caspar, S. Suerbaum, J. G. Fox, A. W. Cheever, D. Jankovic, and A. Sher. 2003. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope. Proc. Natl. Acad. Sci. USA 100:15830-15835.
31. Kullberg, M. C., D. Jankovic, P. L. Gorelick, P. Caspar, J. J. Letterio, A. W. Cheever, and A. Sher. 2002. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 196:505-515.
32. Kullberg, M. C., A. G. Rothfuchs, D. Jankovic, P. Caspar, T. A. Wynn, P. L. Gorelick, A. W. Cheever, and A. Sher. 2001. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect. Immun. 69:4232-4241.
33. Kullberg, M. C., J. M. Ward, P. L. Gorelick, P. Caspar, S. Hieny, A. Cheever, D. Jankovic, and A. Sher. 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66:5157-5166.
34. Maggio-Price, L., D. Shows, K. Waggie, A. Burich, W. Zeng, S. Escobar, P. Morrissey, and J. L. Viney. 2002. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am. J. Pathol. 160:739-751.
35. Martin, R. M., J. L. Brady, and A. M. Lew. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212:187-192. (Pubitemid 28288356)
36. Matsumoto, T., M. Goto, H. Murakami, T. Tanaka, H. Nishiyama, E. Ono, C. Okada, E. Sawabe, M. Yagoshi, A. Yoneyama, K. Okuzumi, K. Tateda, N. Misawa, and K. Yamaguchi. 2007. Multicenter study to evaluate blood-stream infection by Helicobacter cinaedi in Japan. J. Clin. Microbiol. 45:2853-2857.
37. Misawa, N., K. Kawashima, F. Kondo, E. Kushima, K. Kushima, and P. Vandamme. 2002. Isolation and characterization of Campylobacter, Helicobacter, and Anaerobiospirillum strains from a puppy with bloody diarrhea. Vet. Microbiol. 87:353-364.
38. Opal, S. M., J. C. Wherry, and P. Grint. 1998. Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin. Infect. Dis. 27:1497-1507.
39. Orlicek, S. L., D. F. Welch, and T. L. Kuhls. 1993. Septicemia and meningitis caused by Helicobacter cinaedi in a neonate. J. Clin. Microbiol. 31:569-571.
40. Perner, A., and J. Rask-Madsen. 1999. Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders. Aliment. Pharmacol. Ther. 13:135-144.
41. Pratt, J. S., K. L. Sachen, H. D. Wood, K. A. Eaton, and V. B. Young. 2006. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect. Immun. 74:4496-4504.
42. Purdy, D., C. M. Buswell, A. E. Hodgson, K. McAlpine, I. Henderson, and S. A. Leach. 2000. Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni. J. Med. Microbiol. 49:473-479.
43. Rogers, A. B., K. S. Cormier, and J. G. Fox. 2006. Thiol-reactive compounds prevent nonspecific antibody binding in immunohistochemistry. Lab. Investig. 86:526-533.
44. Ruocco, E., A. Cuomo, R. Salerno, V. Ruocco, M. Romano, and A. Baroni. 2007. Crohn's disease and its mucocutaneous involvement. Skinmed 6:179-185.
45. Sawada, M., A. Suzumura, H. Hosoya, T. Marunouchi, and T. Nagatsu. 1999. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J. Neurochem. 72:1466-1471. (Pubitemid 29140817)
46. Sellon, R. K., S. Tonkonogy, M. Schultz, L. A. Dieleman, W. Grenther, E. Balish, D. M. Rennick, and R. B. Sartor. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66:5224-5231.
47. Stills, H. F., Jr., R. R. Hook, Jr., and D. A. Kinden. 1989. Isolation of a Campylobacter-like organism from healthy Syrian hamsters (Mesocricetus auratus). J. Clin. Microbiol. 27:2497-2501.
48. Sugai, M., T. Kawamoto, S. Y. Peres, Y. Ueno, H. Komatsuzawa, T. Fujiwara, H. Kurihara, H. Suginaka, and E. Oswald. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 66:5008-5019.
49. Taylor, N. S., Z. Ge, Z. Shen, F. E. Dewhirst, and J. G. Fox. 2003. Cytolethal distending toxin: a potential virulence factor for Helicobacter cinaedi. J. Infect. Dis. 188:1892-1897.
50. Taylor, N. S., S. Xu, P. Nambiar, F. E. Dewhirst, and J. G. Fox. 2007. Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. J. Clin. Microbiol. 45:2166-2172.
51. Totten, P. A., C. L. Fennell, F. C. Tenover, J. M. Wezenberg, P. L. Perine, W. E. Stamm, and K. K. Holmes. 1985. Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J. Infect. Dis. 151:131-139.
52. Vandamme, P., C. S. Harrington, K. Jalava, and S. L. On. 2000. Misidentifying helicobacters: the Helicobacter cinaedi example. J. Clin. Microbiol. 38:2261-2266.
53. Whary, M. T., J. Cline, A. King, Z. Ge, Z. Shen, B. Sheppard, and J. G. Fox. 2001. Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Comp. Med. 51:413-417.
54. -/-) mice infected with Helicobacter trogontum is associated with decreased colonization by altered Schaedler's flora. Infect. Immun. 74:6615-6623.
55. 2-phase cell cycle block. Infect. Immun. 66:1934-1940.
56. Young, V. B., C. C. Chien, K. A. Knox, N. S. Taylor, D. B. Schauer, and J. G. Fox. 2000. Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum. J. Infect. Dis. 182:620-623.
57. Young, V. B., K. A. Knox, J. S. Pratt, J. S. Cortez, L. S. Mansfield, A. B. Rogers, J. G. Fox, and D. B. Schauer. 2004. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect. Immun. 72:2521-2527.